Bayer Healthcare Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAYER HEALTHCARE LLC, and what generic and branded alternatives to BAYER HEALTHCARE LLC drugs are available?
BAYER HEALTHCARE LLC has twenty-five approved drugs.
Summary for Bayer Healthcare Llc
US Patents: | 0 |
Tradenames: | 20 |
Ingredients: | 10 |
NDAs: | 25 |
Patent Litigation for Bayer Healthcare Llc: | See patent lawsuits for Bayer Healthcare Llc |
Drugs and US Patents for Bayer Healthcare Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Healthcare Llc | CHLOR-TRIMETON | chlorpheniramine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018397-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | |||||
Bayer Healthcare Llc | CLARITIN | loratadine | SYRUP;ORAL | 020641-002 | Nov 27, 2002 | OTC | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | |||||
Bayer Healthcare Llc | LOTRIMIN ULTRA | butenafine hydrochloride | CREAM;TOPICAL | 021307-001 | Dec 7, 2001 | OTC | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bayer Healthcare Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Healthcare Llc | SHADE UVAGUARD | avobenzone; octinoxate; oxybenzone | LOTION;TOPICAL | 020045-001 | Dec 7, 1992 | 4,387,089 | ⤷ Try for Free |
Bayer Healthcare Llc | CLARITIN-D 24 HOUR | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 020470-002 | Nov 27, 2002 | 4,863,931*PED | ⤷ Try for Free |
Bayer Healthcare Llc | CLARITIN-D 24 HOUR | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 020470-002 | Nov 27, 2002 | 4,659,716*PED | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.